These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 30467094)
21. Haplotypes of (-794(CATT) Guevara-Gutiérrez E; Castro-Jonguitud MJ; De la Torre-Flores SE; Muñoz-Valle JF; Tlacuilo-Parra A; Salazar-Torres FJ; Valle Y; Padilla-Gutiérrez JR; Martínez-Fernández DE; Valdés-Alvarado E J Investig Med; 2021 Jan; 69(1):41-46. PubMed ID: 33046523 [TBL] [Abstract][Full Text] [Related]
22. Macrophage migration inhibitory factor promoter polymorphisms (-794 CATT 5-8 and -173 G>C): relationship with mRNA expression and soluble MIF levels in young obese subjects. Matia-García I; Salgado-Goytia L; Muñoz-Valle JF; García-Arellano S; Hernández-Bello J; Salgado-Bernabé AB; Parra-Rojas I Dis Markers; 2015; 2015():461208. PubMed ID: 25972622 [TBL] [Abstract][Full Text] [Related]
23. Circulating soluble levels of MIF in women with breast cancer in the molecular subtypes: relationship with Th17 cytokine profile. Avalos-Navarro G; Muñoz-Valle JF; Daneri-Navarro A; Quintero-Ramos A; Franco-Topete RA; Morán-Mendoza AJ; Oceguera-Villanueva A; Bautista-Herrera LA; Topete-Camacho A; Del Toro-Arreola A Clin Exp Med; 2019 Aug; 19(3):385-391. PubMed ID: 31102004 [TBL] [Abstract][Full Text] [Related]
24. MIF (macrophage migration inhibitory factor) promoter polymorphisms and susceptibility to severe malarial anemia. Awandare GA; Martinson JJ; Were T; Ouma C; Davenport GC; Ong'echa JM; Wang W; Leng L; Ferrell RE; Bucala R; Perkins DJ J Infect Dis; 2009 Aug; 200(4):629-37. PubMed ID: 19591577 [TBL] [Abstract][Full Text] [Related]
25. Association of the genetic variants (-794 CATT5-8 and -173 G > C) of macrophage migration inhibitory factor (MIF) with higher soluble levels of MIF and TNFα in women with breast cancer. Avalos-Navarro G; Del Toro-Arreola A; Daneri-Navarro A; Quintero-Ramos A; Bautista-Herrera LA; Franco Topete RA; Anaya Macias BU; Javalera Castro DI; Morán-Mendoza AJ; Oceguera-Villanueva A; Topete-Camacho A; Muñoz-Valle JF J Clin Lab Anal; 2020 May; 34(5):e23209. PubMed ID: 31978276 [TBL] [Abstract][Full Text] [Related]
26. Effect of IL-34 on T helper 17 cell proliferation and IL-17 secretion by peripheral blood mononuclear cells from rheumatoid arthritis patients. Li X; Lei Y; Gao Z; Zhang B; Xia L; Lu J; Shen H Sci Rep; 2020 Dec; 10(1):22239. PubMed ID: 33335239 [TBL] [Abstract][Full Text] [Related]
27. MIF promotes Th17 cell differentiation in Hashimoto's thyroiditis by binding HVEM and activating NF-κB signaling pathway. Liu Z; Li Z; Yan G; Lin C; Luo Y; Ye Y; Zeng X; Yao J Int Immunopharmacol; 2023 Aug; 121():110494. PubMed ID: 37331297 [TBL] [Abstract][Full Text] [Related]
28. Haplotypes of [-794(CATT) Guevara-Gutiérrez E; Ramos-Súarez M; Villalobos-Ayala RA; Tlacuilo-Parra A; Muñoz-Valle JF; Tarango-Martínez V; Valle Y; Padilla-Gutiérrez JR; Rojas-Díaz JM; Valdés-Alvarado E Mol Genet Genomic Med; 2023 Nov; 11(11):e2252. PubMed ID: 37485818 [TBL] [Abstract][Full Text] [Related]
29. Influence of MIF, CD40, and CD226 polymorphisms on risk of rheumatoid arthritis. Liu R; Xu N; Wang X; Shen L; Zhao G; Zhang H; Fan W Mol Biol Rep; 2012 Jun; 39(6):6915-22. PubMed ID: 22302395 [TBL] [Abstract][Full Text] [Related]
30. Macrophage migration inhibitory factor promoter polymorphisms (-794 CATT5-8): Relationship with soluble MIF levels in coronary atherosclerotic disease subjects. Qian L; Wang XY; Thapa S; Tao LY; Wu SZ; Luo GJ; Wang LP; Wang JN; Wang J; Li J; Tang JF; Ji KT BMC Cardiovasc Disord; 2017 Jun; 17(1):144. PubMed ID: 28578664 [TBL] [Abstract][Full Text] [Related]
31. Macrophage migration inhibitory factor polymorphisms do not predict therapeutic response to glucocorticoids or to tumour necrosis factor alpha-neutralising treatments in rheumatoid arthritis. Radstake TR; Fransen J; Toonen EJ; Coenen MJ; Eijsbouts AE; Donn R; van den Hoogen FH; van Riel PL Ann Rheum Dis; 2007 Nov; 66(11):1525-30. PubMed ID: 17456524 [TBL] [Abstract][Full Text] [Related]
36. Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus. Scuderi F; Convertino R; Molino N; Provenzano C; Marino M; Zoli A; Bartoccioni E Autoimmunity; 2003 Mar; 36(2):71-7. PubMed ID: 12820688 [TBL] [Abstract][Full Text] [Related]
37. Lack of association between macrophage migration inhibitory factor-173 gene polymorphism with disease susceptibility and cardiovascular risk in rheumatoid arthritis patients from northwestern Spain. Palomino-Morales R; Gonzalez-Juanatey C; Vazquez-Rodriguez TR; Torres O; Miranda-Filloy JA; Llorca J; Martin J; Gonzalez-Gay MA Clin Exp Rheumatol; 2010; 28(1):68-72. PubMed ID: 20346241 [TBL] [Abstract][Full Text] [Related]
38. Ex vivo PBMC cytokine profile in familial Mediterranean fever patients: Involvement of IL-1β, IL-1α and Th17-associated cytokines and decrease of Th1 and Th2 cytokines. Ibrahim JN; Jounblat R; Delwail A; Abou-Ghoch J; Salem N; Chouery E; Megarbane A; Medlej-Hashim M; Lecron JC Cytokine; 2014 Oct; 69(2):248-54. PubMed ID: 25025954 [TBL] [Abstract][Full Text] [Related]
39. Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment. Seitz M; Zwicker M; Wider B J Rheumatol; 2001 Mar; 28(3):496-501. PubMed ID: 11296948 [TBL] [Abstract][Full Text] [Related]
40. Macrophage migration inhibitory factor may play a protective role in osteoarthritis. Liu M; Xie Z; Sun G; Chen L; Qi D; Zhang H; Xiong J; Furey A; Rahman P; Lei G; Zhai G Arthritis Res Ther; 2021 Feb; 23(1):59. PubMed ID: 33610191 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]